MBOT
- Microbot Medical Inc.
()
Overview
Company Summary
Microbot Medical Inc. (MBOT) is a medical device company that specializes in the research, development, and commercialization of advanced micro-robotic technology. The company focuses on developing innovative medical solutions to improve minimally invasive surgical procedures.
Microbot Medical's core technology involves the utilization of miniature robots, known as micro-robotics, coupled with artificial intelligence and machine learning capabilities. These micro-robots are designed to be easily controlled by surgeons, allowing for precise and targeted interventions within the human body.
The company's product portfolio includes various robotic platforms and devices that address different medical procedures and conditions. One of its flagship products is the Self-Cleaning Shunt (SCS) for the treatment of hydrocephalus, a neurological disorder that results in excessive accumulation of cerebrospinal fluid in the brain. The SCS is an innovative solution that reduces the need for invasive shunt revision surgeries and helps improve patient outcomes.
Microbot Medical is also developing other micro-robotic platforms for applications such as urology, cardiovascular procedures, ophthalmology, and gastrointestinal endoscopy. For instance, the company is working on an autonomous robotic platform for trans-urethral treatment of bladder tumors, aiming to enhance tumor resection accuracy and minimize the risk of recurrence.
By combining cutting-edge robotics, artificial intelligence, and medical expertise, Microbot Medical aims to revolutionize the field of minimally invasive surgery. The company's innovative technologies have the potential to improve patient outcomes, reduce healthcare costs, and advance the overall standard of care in various medical fields.